A psychosocial intervention for individuals with advanced chronic kidney disease: A feasibility randomized controlled trial

Aim The current study evaluated the feasibility and preliminary efficacy of a psychosocial intervention, the Kidney Optimal Health Program, in reducing symptoms of depression and anxiety in individuals with advanced chronic kidney disease. Methods Patients with stage 4 or 5 chronic kidney disease we...

Full description

Saved in:
Bibliographic Details
Published in:Nephrology (Carlton, Vic.) Vic.), 2021-05, Vol.26 (5), p.442-453
Main Authors: Jenkins, Zoe M., Tan, Eric J., O'Flaherty, Emmet, Knowles, Simon, Thompson, David R., Ski, Chantal F., Rossell, Susan L., Coco, Carolee, Ierino, Francesco L., Gock, Hilton, Castle, David J.
Format: Article
Language:English
Subjects:
Anxiety
Clinical trials
depression
Feasibility studies
kidney disease
Kidney diseases
Mental depression
psychosocial
randomized controlled trial
Retention
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Aim The current study evaluated the feasibility and preliminary efficacy of a psychosocial intervention, the Kidney Optimal Health Program, in reducing symptoms of depression and anxiety in individuals with advanced chronic kidney disease. Methods Patients with stage 4 or 5 chronic kidney disease were randomized to either a nine‐session psychosocial intervention programme or usual care. Feasibility was assessed through recruitment and retention rates and programme acceptability. Participants completed assessments of depression, anxiety and psychosocial health at baseline and at 3‐, 6‐ and 12‐month follow‐up. A repeated‐measures analysis of variance was used to compare groups on outcomes over time. Results One hundred and twenty‐eight patients were screened for eligibility; 84 consented to participant and were randomized to receive the intervention (N = 42) or usual care (N = 42). 27 (32.1%) participants withdrew prior to baseline assessment. Of those who completed the baseline assessment (N = 57), trial retention was high (75.4% at 3‐month, 80.7% at 6‐month and 70.2% at 12‐month follow‐up). Participants reported high levels of programme acceptability. The patients who completed the intervention (N = 17) demonstrated significantly decreased depression at 12‐month follow‐up compared to the usual care group (N = 13). Conclusion The results support the feasibility of the Kidney Optimal Health Program intervention in recruitment, retention and programme acceptability with an improved screening protocol. Preliminary support is provided for improvement in depressive symptoms in patients with advanced chronic kidney disease. Further investigation through a fully powered randomized controlled trial is warranted. SUMMARY AT A GLANCE This study demonstrated that a psychosocial intervention programme, the Kidney Optimal Health Program, is feasible and efficacious in reducing symptoms of depression and anxiety in individuals with advanced chronic kidney disease.
ISSN:1320-5358
1440-1797
DOI:10.1111/nep.13850